Cargando…
Type 1 Diabetes Prevention in NOD Mice by Targeting DPPIV/CD26 Is Associated with Changes in CD8(+)T Effector Memory Subset
CD26 is a T cell activation marker consisting in a type II transmembrane glycoprotein with dipeptidyl peptidase IV (DPPIV) activity in its extracellular domain. It has been described that DPPIV inhibition delays the onset of type 1 diabetes and reverses the disease in non-obese diabetic (NOD) mice....
Autores principales: | Alonso, Núria, Julián, María Teresa, Carrascal, Jorge, Colobran, Roger, Pujol-Autonell, Irma, Rodriguez-Fernández, Silvia, Teniente, Aina, Fernández, Marco Antonio, Miñarro, Antoni, Ruiz de Villa, María Carmen, Vives-Pi, Marta, Puig-Domingo, Manel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640511/ https://www.ncbi.nlm.nih.gov/pubmed/26555789 http://dx.doi.org/10.1371/journal.pone.0142186 |
Ejemplares similares
-
Immunotherapy with Tolerogenic Dendritic Cells Alone or in Combination with Rapamycin Does Not Reverse Diabetes in NOD Mice
por: Pujol-Autonell, Irma, et al.
Publicado: (2013) -
How apoptotic β-cells direct immune response to tolerance or to autoimmune diabetes: a review
por: Vives-Pi, Marta, et al.
Publicado: (2015) -
Efferocytosis Promotes Suppressive Effects on Dendritic Cells through Prostaglandin E2 Production in the Context of Autoimmunity
por: Pujol-Autonell, Irma, et al.
Publicado: (2013) -
Differential Expression and Enzymatic Activity of DPPIV/CD26 Affects Migration Ability of Cervical Carcinoma Cells
por: Beckenkamp, Aline, et al.
Publicado: (2015) -
Apigenin upregulation of CD26/DPPIV on colon epithelial cells requires inhibition of casein kinase 2
por: Lefort, Émilie C., et al.
Publicado: (2020)